相关实验视频
Updated: Jul 2, 2025

13:28
Methodology for Sputum Induction and Laboratory Processing
Published on: December 17, 2017
27.6K
静脉注射硫酸治疗儿童喘恶化:系统性审查与元分析
Dominika Ambrożej1, Aleksander Adamiec1, Erick Forno2
1Department of Pediatric Pneumonology and Allergy, Medical University of Warsaw, Warsaw, Poland; Doctoral School, Medical University of Warsaw, Warsaw, Poland.
Paediatric respiratory reviews
|February 23, 2024
概括
静脉注射硫酸 (IV-MgSO4) 减少住院治疗,并改善患有喘恶化儿童的肺功能. 副作用很少见,但需要进一步的研究才能得出最终的结论.
科学领域:
- 儿科肺病学 儿科肺病学
- 临床药理学 临床药理学
背景情况:
- 喘是主要的慢性儿童疾病之一,对医疗保健构成重大挑战.
- 目前针对急性喘恶化的一线治疗方法已经确立,但像IV-MgSO4这样的二次治疗方法缺乏关于有效性和安全性的可靠数据.
研究的目的:
- 评估静脉注射硫酸 (IV-MgSO4) 作为小儿喘恶化次要治疗的有效性和安全性.
主要方法:
- 一个系统的审查和随机临床试验 (RCTs) 的元分析发表到2023年4月.
- 在五个数据库中搜索了IV-MgSO4在急性喘恶化儿童中的研究.
- 主要结局包括住院率,住院时间和严重程度;次要结局包括肺功能 (PEFR),再入院,PICU需求和不良事件.
主要成果:
- 包括11项研究. IV-MgSO4显著降低了住院风险 (OR 0.15;95%CI:0.03,0.73) 和改善了肺功能 (26.77%的PEFR增加;95%CI:18.41,54.79).
- 两组之间没有观察到医院住院时间的显著差异.
- 由于异质性,其他结果被叙述合成.
结论:
- 在儿童喘恶化中,IV-MgSO4在降低住院率和增强肺功能方面表现有前途.
- 与IV-MgSO4相关的不良反应并不常见.
- 建议进一步进行高质量的研究,以充分阐明IV-MgSO4在这个人群中的疗效和安全性.
相关概念视频
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
297
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
297
Antiasthma Drugs: Methylxanthines
229
Theophylline, a member of the methylxanthine class of bronchodilators, has long been used in asthma management. While its exact mechanism of action is not fully understood, it is believed to have multiple effects on various cellular processes.
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
229
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
247
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
247
Antiasthma Drugs: β2-Adrenoceptor Agonists
264
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
264
Asthma: Pathogenesis and Management
398
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
398

